CCMD
AMGN icon

Cypress Capital Management (Delaware)’s Amgen AMGN Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,818
Closed -$861K – 10
2022
Q3 		$861K Buy
3,818
+1,341
+54% +$325K 0.16% 105
2022
Q2 		$603K Sell
2,477
-45
-2% -$11K 0.09% 133
2022
Q1 		$610K Sell
2,522
-85
-3% -$19.5K 0.08% 133
2021
Q4 		$586K Sell
2,607
-99
-4% -$20.9K 0.07% 140
2021
Q3 		$660K Hold
2,706
– – 0.09% 120
2021
Q2 		$660K Sell
2,706
-275
-9% -$67.7K 0.09% 121
2021
Q1 		$742K Sell
2,981
-125
-4% -$29.8K 0.1% 116
2020
Q4 		$714K Hold
3,106
– – 0.1% 113
2020
Q3 		$789K Hold
3,106
– – 0.12% 103
2020
Q2 		$733K Hold
3,106
– – 0.12% 103
2020
Q1 		$630K Sell
3,106
-50
-2% -$10.9K 0.12% 99
2019
Q4 		$761K Sell
3,156
-50
-2% -$11K 0.12% 105
2019
Q3 		$620K Sell
3,206
-5
-0.2% -$960 0.1% 109
2019
Q2 		$592K Sell
3,211
-234
-7% -$41.9K 0.1% 112
2019
Q1 		$654K Sell
3,445
-855
-20% -$163K 0.12% 97
2018
Q4 		$837K Buy
4,300
+35
+0.8% +$6.83K 0.17% 76
2018
Q3 		$884K Sell
4,265
-155
-4% -$30.5K 0.15% 77
2018
Q2 		$816K Buy
4,420
+100
+2% +$17.7K 0.16% 85
2018
Q1 		$736K Sell
4,320
-1,155
-21% -$212K 0.14% 85
2017
Q4 		$952K Buy
5,475
+45
+0.8% +$7.96K 0.18% 72
2017
Q3 		$1.01M Buy
5,430
+85
+2% +$15.1K 0.21% 66
2017
Q2 		$921K Buy
5,345
+1,985
+59% +$323K 0.22% 62
2017
Q1 		$551K Buy
3,360
+1,115
+50% +$185K 0.14% 69
2016
Q4 		$328K Buy
+2,245
New +$338K 0.09% 83

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cypress Capital Management (Delaware)'s AMGN Position: Q4 2022 in Review

Cypress Capital Management (Delaware) sold out of Amgen (AMGN) in Q4 2022, closing a stake of 3,818 shares — an estimated $861K sold.

Cypress Capital Management (Delaware) first reported a position in AMGN in Q4 2016 and held it in 24 quarters. The position peaked at $1.01M in Q3 2017. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Cypress Capital Management (Delaware) reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 3,818 Amgen shares in Q4 2022, an estimated $861K.
  • Cypress Capital Management (Delaware) first reported a position in Amgen in Q4 2016 and held it in 24 quarters.
  • Cypress Capital Management (Delaware)'s Amgen position peaked at $1.01M in Q3 2017.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q4 2022.